| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |